Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 16 studies | 57% ± 22% | |
peripheral blood | 15 studies | 82% ± 14% | |
intestine | 13 studies | 42% ± 22% | |
brain | 11 studies | 35% ± 22% | |
liver | 7 studies | 49% ± 23% | |
kidney | 7 studies | 58% ± 25% | |
bone marrow | 6 studies | 54% ± 34% | |
eye | 5 studies | 57% ± 19% | |
breast | 4 studies | 62% ± 19% | |
uterus | 3 studies | 74% ± 15% | |
prostate | 3 studies | 29% ± 3% | |
skin | 3 studies | 48% ± 14% | |
lymph node | 3 studies | 84% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
stomach | 99% | 162790.91 | 357 / 359 | 98% | 11140.30 | 281 / 286 |
adrenal gland | 100% | 219015.28 | 258 / 258 | 97% | 11482.95 | 224 / 230 |
brain | 100% | 241258.16 | 2630 / 2642 | 97% | 8349.03 | 687 / 705 |
esophagus | 97% | 117639.54 | 1398 / 1445 | 100% | 8316.15 | 183 / 183 |
kidney | 97% | 274592.75 | 86 / 89 | 98% | 12185.00 | 884 / 901 |
intestine | 98% | 141242.92 | 942 / 966 | 97% | 8792.73 | 511 / 527 |
skin | 97% | 78384.86 | 1761 / 1809 | 97% | 6914.58 | 457 / 472 |
prostate | 98% | 132550.14 | 240 / 245 | 92% | 7674.69 | 462 / 502 |
breast | 97% | 115990.73 | 447 / 459 | 93% | 5409.58 | 1035 / 1118 |
pancreas | 96% | 68932.28 | 316 / 328 | 93% | 6483.87 | 165 / 178 |
bladder | 95% | 115393.14 | 20 / 21 | 91% | 7188.74 | 457 / 504 |
liver | 100% | 284504.56 | 225 / 226 | 86% | 6507.20 | 350 / 406 |
lung | 88% | 66293.86 | 509 / 578 | 93% | 5640.73 | 1075 / 1155 |
thymus | 90% | 91666.29 | 585 / 653 | 88% | 6138.53 | 533 / 605 |
ovary | 67% | 47051.88 | 120 / 180 | 100% | 8860.15 | 429 / 430 |
uterus | 88% | 57788.44 | 149 / 170 | 78% | 3825.36 | 358 / 459 |
eye | 0% | 0 | 0 / 0 | 100% | 11727.05 | 80 / 80 |
heart | 100% | 383411.19 | 861 / 861 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 18025.53 | 1 / 1 |
muscle | 100% | 192059.47 | 801 / 803 | 0% | 0 | 0 / 0 |
adipose | 97% | 122764.74 | 1172 / 1204 | 0% | 0 | 0 / 0 |
spleen | 84% | 54518.20 | 202 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 73% | 2452.96 | 33 / 45 |
blood vessel | 69% | 42234.60 | 918 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 59% | 2505.22 | 17 / 29 |
peripheral blood | 22% | 14772.68 | 200 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0009060 | Biological process | aerobic respiration |
GO_0006120 | Biological process | mitochondrial electron transport, NADH to ubiquinone |
GO_0042776 | Biological process | proton motive force-driven mitochondrial ATP synthesis |
GO_0055085 | Biological process | transmembrane transport |
GO_0045271 | Cellular component | respiratory chain complex I |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0008137 | Molecular function | NADH dehydrogenase (ubiquinone) activity |
Gene name | MT-ND4L |
Protein name | NADH-ubiquinone oxidoreductase chain 4L (EC 7.1.1.2) (NADH dehydrogenase subunit 4L) (ND4L) |
Synonyms | MTND4L NADH4L ND4L |
Description | FUNCTION: Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor . Part of the enzyme membrane arm which is embedded in the lipid bilayer and involved in proton translocation . . |
Accessions | ENST00000361335.1 P03901 |